NCT03729232 (J-AB) is a clinical trial in Catheter Ablation, sponsored by National Cerebral and Cardiovascular Center, Japan.

Who is sponsoring NCT03729232?

NCT03729232 is sponsored by National Cerebral and Cardiovascular Center, Japan.

What condition does NCT03729232 study?

NCT03729232 studies Catheter Ablation, Cardiac Arrhythmias.

Is NCT03729232 still recruiting?

NCT03729232 is currently recruiting now. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT03729232: J-AB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Japanese Catheter Ablation Registry

Recruiting now Last updated 13 November 2023

What this trial tests

trial in Catheter Ablation in 400,000 participants. Currently enrolling.

Timeline

1 July 2017

Primary endpoint
31 March 2030

31 March 2030

Quick facts

Lead sponsor	National Cerebral and Cardiovascular Center, Japan
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	400,000
Start date	1 July 2017
Primary completion	31 March 2030
Estimated completion	31 March 2030
Sites	1 location across Japan

Conditions studied

Catheter Ablation — all drugs for Catheter Ablation →
Cardiac Arrhythmias — all drugs for Cardiac Arrhythmias →

Sponsor

National Cerebral and Cardiovascular Center, Japan — full company profile →

Who can join

Eligibility, any sex, with Catheter Ablation or Cardiac Arrhythmias. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

The Japanese Catheter Ablation Registry (J-AB): A prospective nationwide multicenter registry in Japan. Annual report in 2018.
Kusano K, Yamane T, Inoue K, Takegami M, et al · · 2020 · cited 25× · PMID 33335609 · DOI 10.1002/joa3.12445
The Japanese Catheter Ablation Registry (J-AB): Annual report in 2020.
Kusano K, Yamane T, Inoue K, Takegami M, et al · · 2022 · cited 17× · PMID 36237868 · DOI 10.1002/joa3.12772
The Japanese Catheter Ablation Registry (J-AB): Annual report in 2019.
Kusano K, Yamane T, Inoue K, Takegami M, et al · · 2021 · cited 16× · PMID 34887948 · DOI 10.1002/joa3.12640
Study design of nationwide Japanese Catheter Ablation Registry: Protocol for a prospective, multicenter, open registry.
Yamane T, Inoue K, Kusano K, Takegami M, et al · · 2019 · cited 13× · PMID 31007779 · DOI 10.1002/joa3.12163
The Japanese Catheter Ablation Registry (J-AB): Annual report in 2022.
Kusano K, Inoue K, Kanaoka K, Miyamoto K, et al · · 2024 · cited 11× · PMID 39416252 · DOI 10.1002/joa3.13141
The Japanese Catheter Ablation Registry (J-AB): Annual report in 2021.
Kusano K, Yamane T, Inoue K, Takegami M, et al · · 2023 · cited 10× · PMID 38045445 · DOI 10.1002/joa3.12931
The Japanese Catheter Ablation Registry (J-AB): Annual Report in 2023.
Kusano K, Inoue K, Kanaoka K, Miyamoto K, et al · · 2025 · cited 2× · PMID 40861251 · DOI 10.1002/joa3.70173
Real-World Outcomes of Repeat Ablation Strategies for Atrial Fibrillation: Insights From the Japanese Catheter Ablation Registry.
Matsuda Y, Masuda M, Kanaoka K, Mano T, et al · · 2025 · cited 1× · PMID 40995616 · DOI 10.1002/joa3.70200

Verify or expand the search:

Other recruiting trials for Catheter Ablation

Currently open trials in the same condition.

NCT07047235 — Substrate Remodelling and Targeted Ablation in AF · NA · recruiting
NCT06953752 — Effects of Music During Atrial Fibrillation Ablation Under Conscious Sedation · NA · recruiting
NCT07078760 — Lattice-tip Versus Irrigated-tip Catheter for Linear Ablation of the Cavotricuspid Isthmus. A Multicenter, Randomized St · NA · recruiting
NCT06883864 — Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation · NA · recruiting
NCT06691074 — Cavo-Tricuspid Isthmus Block Durability After Pulsed Electric Field Ablation · NA · recruiting

Other National Cerebral and Cardiovascular Center, Japan trials

Trials by the same sponsor.

NCT06072118 — Adrenomedullin for CADASIL · Phase 2 · completed
NCT04559191 — Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring · Phase 4 · unknown
NCT04864171 — REASSURE-NIRS Registry · recruiting
NCT04345627 — Japanese Lead Extraction Registry · recruiting
NCT02491268 — A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03729232 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Cerebral and Cardiovascular Center, Japan
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03729232.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing